Please check your internet connection and try again.
# Hepamerz (L-Ornithine L-Aspartate)
## Overview
Hepamerz is a combination of the amino acids L-ornithine and L-aspartate. It is thought to facilitate the detoxification of ammonia in the liver.
## Primary Indications
Treatment of latent and overt hepatic encephalopathy (HE) associated with hyperammonemia, primarily in patients with liver cirrhosis.
## Adult Dosing
* **Oral:** Typically 3 to 6 g three times daily. Higher doses may be used under strict medical supervision.
* **Intravenous (IV):** Usually 5 g once or twice daily, diluted in a suitable IV fluid (e.g., 0.9% sodium chloride, 5% dextrose). The total daily dose should not exceed 10 g. Dosing and rate of infusion may vary based on patient status and local protocols.
## Pediatric Dosing
Dosing in pediatric patients is not well-established. Use should be guided by expert opinion and careful monitoring. Some sources suggest an oral dose of 100-200 mg/kg/day in divided doses.
## Dose Adjustments
No specific dose adjustments are typically required for renal or hepatic impairment, as the drug is metabolized and excreted primarily by the liver. However, caution and monitoring are advised in patients with severe renal dysfunction due to potential accumulation of ornithine.
## Contraindications
* Known hypersensitivity to L-ornithine L-aspartate or any component of the formulation.
* Severe renal failure (creatinine clearance < 25 mL/min or serum creatinine > 3 mg/dL) due to potential risk of hyperornithinemia.
* Hereditary conditions such as argininosuccinic aciduria.
## Adverse Effects
* **Gastrointestinal:** Nausea, vomiting, abdominal pain, diarrhea.
* **Other:** Dizziness, headache, fatigue, allergic reactions (rare).
* **IV administration:** Local reactions at the injection site (pain, phlebitis).
## Key Drug Interactions
No significant drug interactions have been definitively established. However, caution should be exercised when co-administering with other medications that affect ammonia levels or liver function.
## Monitoring
* Monitor for signs and symptoms of hepatic encephalopathy.
* Assess ammonia levels periodically.
* Monitor renal function, especially in patients with pre-existing renal impairment.
* Observe for adverse effects.
## Clinical Pearls
* Hepamerz is most effective when initiated early in the course of hepatic encephalopathy.
* The oral form may have a slower onset of action compared to the IV form.
* Ensure adequate hydration when administering IV.
* It is crucial to continue to manage the underlying liver disease and precipitating factors of HE.
---
*Disclaimer: This information is intended for educational purposes and does not substitute for professional medical advice. Always consult the current prescribing information and a qualified healthcare provider for any medical decisions. The information provided here may not be exhaustive and does not cover all possible drug interactions, adverse effects, or contraindications.*
